Australia markets close in 2 hours 50 minutes

Bausch + Lomb Corporation (BLCO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
17.21-0.08 (-0.46%)
At close: 04:00PM EST
17.21 0.00 (0.00%)
After hours: 05:35PM EST
Full screen
Trade prices are not sourced from all markets
Previous close17.29
Open17.20
Bid17.42 x 800
Ask17.43 x 1100
Day's range17.02 - 17.44
52-week range12.20 - 20.20
Volume153,733
Avg. volume373,863
Market cap6.024B
Beta (5Y monthly)N/A
PE ratio (TTM)101.24
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)

    VAUGHAN, Ontario & TAMPERE, Finland, February 01, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation ("Modulight"), a biomedical laser company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the

  • Business Wire

    Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

    VAUGHAN, Ontario, January 23, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2022 financial results on Wednesday, Feb. 22, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausc

  • Business Wire

    Bausch + Lomb Acquires AcuFocus, Inc.

    VAUGHAN, Ontario & IRVINE, Calif., January 17, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. ("AcuFocus"), a privately held ophthalmic medical device company, today announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus.